The BCR-ABL positive CML (Chronic Myeloid Leukaemia) cells also lower the expression of mlh1 and pms2 and induce point mutations thus affecting the mismatch repair mechanisms34,35. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.